Health -
ProMIS Neurosciences announces identification of a third novel therapeutic target for Alzheimer’s disease
TSX: PMN TORONTO, March 18, 2016 /CNW/ – ProMIS Neurosciences (“ProMIS” or the “Company”) today announced that, following the identification of […]